Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: One more try

They may not have wordsmithed this to the nth degree. With the limited information provided, you would think, this should have occurred. My guess goes with the English faux pas.

If J3 did not agree, we would be going to trial next week. They had to agree. There may or may not have been contingencies.

"Business resolution" sounds like what Verigy got but they have not been added like Verigy to the licensure list?? There are many unanswered areas (probably 20 or 30) that we will not know about until the April Quarterly report release. Even then, I bet that there will be a lot of questions left unanswered, that may never be answered. For example, if there was not an SEC requirement, we may not really know nuttin' now and into the future. As they say, the law is a double edged sword.

Share
New Message
Please login to post a reply